{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:48:39Z","timestamp":1783648119369,"version":"3.55.0"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Adrenocortical carcinoma (ACC) is a rare and highly heterogeneous disease with a notably poor prognosis due to significant challenges in diagnosis and treatment. Emphasizing on the importance of precision medicine, there is an increasing need for comprehensive genomic resources alongside well-developed experimental models to devise personalized therapeutic strategies. We present ACC_CellMinerCDB, a substantive genomic and drug sensitivity database (available at https:\/\/discover.nci.nih.gov\/acc_cellminercdb) comprising ACC cell lines, patient-derived xenografts, surgical samples, and responses to more than 2,400 drugs examined by the NCI and National Center for Advancing Translational Sciences. This database exposes shared genomic pathways among ACC cell lines and surgical samples, thus authenticating the cell lines as research models. It also allows exploration of pertinent treatment markers such as MDR-1, SOAT1, MGMT, MMR, and SLFN11 and introduces the potential to repurpose agents like temozolomide for ACC therapy. ACC_CellMinerCDB provides the foundation for exploring larger preclinical ACC models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>ACC_CellMinerCDB, a comprehensive database of cell lines, patient-derived xenografts, surgical samples, and drug responses, reveals shared genomic pathways and treatment-relevant markers in ACC. This resource offers insights into potential therapeutic targets and the opportunity to repurpose existing drugs for ACC therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0100","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T04:43:45Z","timestamp":1724129025000},"page":"2384-2398","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-0282","authenticated-orcid":false,"given":"Yasuhiro","family":"Arakawa","sequence":"first","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7116-508X","authenticated-orcid":false,"given":"Fathi","family":"Elloumi","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4096-4782","authenticated-orcid":false,"given":"Sudhir","family":"Varma","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-2189","authenticated-orcid":false,"given":"Prashant","family":"Khandagale","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2826-1355","authenticated-orcid":false,"given":"Ukhyun","family":"Jo","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-8259","authenticated-orcid":false,"given":"Suresh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-5468","authenticated-orcid":false,"given":"Nitin","family":"Roper","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5513-9323","authenticated-orcid":false,"given":"William C.","family":"Reinhold","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0857-3650","authenticated-orcid":false,"given":"Robert W.","family":"Robey","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-4954","authenticated-orcid":false,"given":"Naoko","family":"Takebe","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8908-2097","authenticated-orcid":false,"given":"Michael M.","family":"Gottesman","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-9001","authenticated-orcid":false,"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Rockville, Maryland. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4382-7185","authenticated-orcid":false,"given":"Valentina","family":"Boeva","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Institute for Machine Learning, ETH Zurich, Zurich, Switzerland. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-0043","authenticated-orcid":false,"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Medical Oncology Unit, University of Brescia, Azienda Socio Sanitaria Territoriale (ASST) Spedali Civili, Brescia, Italy. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-0916","authenticated-orcid":false,"given":"Andrea","family":"Abate","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7827-0025","authenticated-orcid":false,"given":"Mariangela","family":"Tamburello","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3294-4121","authenticated-orcid":false,"given":"Sandra","family":"Sigala","sequence":"additional","affiliation":[{"name":"Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8906-2563","authenticated-orcid":false,"given":"Constanze","family":"Hantel","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, and University of Zurich, Z\u00fcrich, Switzerland. 8"},{"name":"Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany. 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5873-8567","authenticated-orcid":false,"given":"Isabel","family":"Weigand","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetology, Department of Internal Medicine I, University Hospital, University of W\u00fcrzburg, W\u00fcrzburg, Germany. 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-1093","authenticated-orcid":false,"given":"Margaret E.","family":"Wierman","sequence":"additional","affiliation":[{"name":"Department of Medicine-Endocrinology\/Metabolism\/Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-582X","authenticated-orcid":false,"given":"Katja","family":"Kiseljak-Vassiliades","sequence":"additional","affiliation":[{"name":"Department of Medicine-Endocrinology\/Metabolism\/Diabetes, University of Colorado, Anschutz Medical Campus, Aurora, Colorado. 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-4030","authenticated-orcid":false,"given":"Jaydira","family":"Del Rivero","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-0758","authenticated-orcid":false,"given":"Yves","family":"Pommier","sequence":"additional","affiliation":[{"name":"Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"2025040317214943200_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.seminoncol.2010.10.011","article-title":"Practical considerations in the evaluation and management of adrenocortical cancer","volume":"37","author":"Balasubramaniam","year":"2010","journal-title":"Semin Oncol"},{"key":"2025040317214943200_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.14740\/jocmr3503w","article-title":"The characteristics and trends in adrenocortical carcinoma: a United States population based study","volume":"10","author":"Sharma","year":"2018","journal-title":"J Clin Med Res"},{"key":"2025040317214943200_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MED.0b013e3282fdf4c0","article-title":"Adjunctive treatment of adrenocortical carcinoma","volume":"15","author":"Terzolo","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2025040317214943200_bib4","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"2025040317214943200_bib5","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040317214943200_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assi\u00e9","year":"2014","journal-title":"Nat Genet"},{"key":"2025040317214943200_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"2025040317214943200_bib8","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12020-019-02033-5","article-title":"IGF2 role in adrenocortical carcinoma biology","volume":"66","author":"Pereira","year":"2019","journal-title":"Endocrine"},{"key":"2025040317214943200_bib9","first-page":"483","article-title":"Mutations of the p53 gene in human functional adrenal neoplasms","volume":"78","author":"Lin","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040317214943200_bib10","first-page":"1116","article-title":"Comparative genomic hybridization analysis of adrenocortical tumors of childhood","volume":"84","author":"Figueiredo","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040317214943200_bib11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/hupa.2000.20409","article-title":"Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation?","volume":"31","author":"Berends","year":"2000","journal-title":"Hum Pathol"},{"key":"2025040317214943200_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/modpathol.3800150","article-title":"Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome","volume":"17","author":"Broaddus","year":"2004","journal-title":"Mod Pathol"},{"key":"2025040317214943200_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mce.2011.12.008","article-title":"Association of adrenocortical carcinoma with familial cancer susceptibility syndromes","volume":"351","author":"Else","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2025040317214943200_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-3476(70)80472-3","article-title":"Neurofibromatosis in childhood","volume":"76","author":"Fienman","year":"1970","journal-title":"J Pediatr"},{"key":"2025040317214943200_bib15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM198604173141603","article-title":"Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms","volume":"314","author":"S\u00f8rensen","year":"1986","journal-title":"N Engl J Med"},{"key":"2025040317214943200_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/EJE-17-0358","article-title":"Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series","volume":"177","author":"Else","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2025040317214943200_bib17","first-page":"5488","article-title":"Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis","volume":"50","author":"Gazdar","year":"1990","journal-title":"Cancer Res"},{"key":"2025040317214943200_bib18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/ERC-17-0447","article-title":"Development of new preclinical models to advance adrenocortical carcinoma research","volume":"25","author":"Kiseljak-Vassiliades","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2025040317214943200_bib19","first-page":"691","article-title":"New human cancer cell culture lines. I. SW-13, small-cell carcinoma of the adrenal cortex","volume":"51","author":"Leibovitz","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"2025040317214943200_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mce.2011.08.041","article-title":"Human adrenocortical carcinoma cell lines","volume":"351","author":"Wang","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"2025040317214943200_bib21","doi-asserted-by":"crossref","first-page":"79292","DOI":"10.18632\/oncotarget.12685","article-title":"Targeting heterogeneity of adrenocortical carcinoma: evaluation and extension of preclinical tumor models to improve clinical translation","volume":"7","author":"Hantel","year":"2016","journal-title":"Oncotarget"},{"key":"2025040317214943200_bib22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/EJE-20-1423","article-title":"A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden","volume":"184","author":"Landwehr","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"2025040317214943200_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.coemr.2019.08.009","article-title":"Contemporary preclinical human models of adrenocortical carcinoma","volume":"8","author":"Pinto","year":"2019","journal-title":"Curr Opin Endocr Metab Res"},{"key":"2025040317214943200_bib24","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/cells11091439","article-title":"A comprehensive investigation of steroidogenic signaling in classical and new experimental cell models of adrenocortical carcinoma","volume":"11","author":"Sigala","year":"2022","journal-title":"Cells"},{"key":"2025040317214943200_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13148-023-01534-5","article-title":"DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma","volume":"15","author":"Kerdivel","year":"2023","journal-title":"Clin Epigenetics"},{"key":"2025040317214943200_bib26","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkaa968","article-title":"CellMiner Cross-Database (CellMinerCDB) version 1.2: exploration of patient-derived cancer cell line pharmacogenomics","volume":"49","author":"Luna","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2025040317214943200_bib27","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1158\/0008-5472.CAN-22-2996","article-title":"CellMinerCDB: NCATS is a web-based portal integrating public cancer cell line databases for pharmacogenomic explorations","volume":"83","author":"Reinhold","year":"2023","journal-title":"Cancer Res"},{"key":"2025040317214943200_bib28","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ccell.2021.02.014","article-title":"Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress","volume":"39","author":"Thomas","year":"2021","journal-title":"Cancer Cell"},{"key":"2025040317214943200_bib29","doi-asserted-by":"crossref","first-page":"eaaw0064","DOI":"10.1126\/scitranslmed.aaw0064","article-title":"Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening","volume":"11","author":"Lin","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025040317214943200_bib30","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040317214943200_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma","volume":"99","author":"Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040317214943200_bib32","doi-asserted-by":"crossref","first-page":"R215","DOI":"10.1530\/EJE-18-0027","article-title":"Management of endocrine disease: adrenocortical carcinoma: differentiating the good from the poor prognosis tumors","volume":"178","author":"Jouinot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2025040317214943200_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2025040317214943200_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/ERC-18-0500","article-title":"MDR1 inhibition increases sensitivity to doxorubicin and etoposide in adrenocortical cancer","volume":"26","author":"Creemers","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"2025040317214943200_bib35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1158\/2767-9764.CRC-24-0085","article-title":"Activity of the ubiquitin-activating enzyme inhibitor TAK-243 in adrenocortical carcinoma cell lines, patient-derived organoids, and murine xenografts","volume":"4","author":"Arakawa","year":"2024","journal-title":"Cancer Res Commun"},{"key":"2025040317214943200_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/tlcr.2018.02.02","article-title":"Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes","volume":"7","author":"Zhang","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"2025040317214943200_bib37","doi-asserted-by":"crossref","first-page":"e49020","DOI":"10.7554\/eLife.49020","article-title":"Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction","volume":"8","author":"Wang","year":"2019","journal-title":"Elife"},{"key":"2025040317214943200_bib38","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1535-7163.MCT-20-1026","article-title":"Novel and highly potent ATR inhibitor M4344 kills cancer cells with replication stress, and enhances the chemotherapeutic activity of widely used DNA damaging agents","volume":"20","author":"Jo","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"2025040317214943200_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/2767-9764.CRC-22-0168","article-title":"Replication stress defines distinct molecular subtypes across cancers","volume":"2","author":"Takahashi","year":"2022","journal-title":"Cancer Res Commun"},{"key":"2025040317214943200_bib40","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.3390\/cancers14215279","article-title":"Comprehensive characterization of the regulatory landscape of adrenocortical carcinoma: novel transcription factors and targets associated with prognosis","volume":"14","author":"Muzzi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025040317214943200_bib41","doi-asserted-by":"crossref","first-page":"613248","DOI":"10.3389\/fendo.2021.613248","article-title":"Current status and future targeted therapy in adrenocortical cancer","volume":"12","author":"Alyateem","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025040317214943200_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1677\/erc.1.1315","article-title":"Mitotane increases the radiotherapy inhibitory effect and induces G2-arrest in combined treatment on both H295R and SW13 adrenocortical cell lines","volume":"15","author":"Cerquetti","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"2025040317214943200_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1530\/EJE-13-0778","article-title":"Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas","volume":"170","author":"Ragazzon","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2025040317214943200_bib44","doi-asserted-by":"crossref","first-page":"E493","DOI":"10.1210\/jc.2014-3282","article-title":"Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma","volume":"100","author":"Juhlin","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040317214943200_bib45","doi-asserted-by":"crossref","first-page":"dmm049362","DOI":"10.1242\/dmm.049362","article-title":"RAS and beyond: the many faces of the neurofibromatosis type 1 protein","volume":"15","author":"Anastasaki","year":"2022","journal-title":"Dis Model Mech"},{"key":"2025040317214943200_bib46","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1245\/s10434-022-12725-4","article-title":"Mitotane with or without cisplatin and etoposide for patients with a high risk of recurrence in stages 1-3 adrenocortical cancer after surgery","volume":"30","author":"Sarvestani","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2025040317214943200_bib47","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1210\/en.2015-1367","article-title":"Mitotane inhibits Sterol-O-acyl Transferase 1 triggering lipid-mediated endoplasmic reticulum stress and apoptosis in adrenocortical carcinoma cells","volume":"156","author":"Sbiera","year":"2015","journal-title":"Endocrinology"},{"key":"2025040317214943200_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12672-020-00385-3","article-title":"Advanced adrenocortical carcinoma (ACC): a review with focus on second-line therapies","volume":"11","author":"Ardolino","year":"2020","journal-title":"Horm Cancer"},{"key":"2025040317214943200_bib49","doi-asserted-by":"crossref","first-page":"107922","DOI":"10.1016\/j.pharmthera.2021.107922","article-title":"Genotoxic therapy and resistance mechanism in gliomas","volume":"228","author":"Lang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"2025040317214943200_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2019.05.009","article-title":"Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies","volume":"201","author":"Murai","year":"2019","journal-title":"Pharmacol Ther"},{"key":"2025040317214943200_bib51","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.3390\/cancers13184601","article-title":"Precision oncology with drugs targeting the replication stress, ATR, and schlafen 11","volume":"13","author":"Jo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025040317214943200_bib52","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1038\/ncomms7302","article-title":"Genomic landscape of paediatric adrenocortical tumours","volume":"6","author":"Pinto","year":"2015","journal-title":"Nat Commun"},{"key":"2025040317214943200_bib53","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41574-019-0221-7","article-title":"Adrenocortical carcinoma - towards genomics guided clinical care","volume":"15","author":"Crona","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"2025040317214943200_bib54","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.3390\/cancers15112873","article-title":"Preclinical models of adrenocortical cancer","volume":"15","author":"Sedlack","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2025040317214943200_bib55","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12020-022-03112-w","article-title":"An update on adrenocortical cell lines of human origin","volume":"77","author":"Sigala","year":"2022","journal-title":"Endocrine"},{"key":"2025040317214943200_bib56","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-022-05096-x","article-title":"Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin","volume":"13","author":"Bornstein","year":"2022","journal-title":"Cell Death Dis"},{"key":"2025040317214943200_bib57","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1210\/js.2018-00197","article-title":"Therapeutic targets for adrenocortical carcinoma in the genomics era","volume":"2","author":"Mohan","year":"2018","journal-title":"J Endocr Soc"},{"key":"2025040317214943200_bib58","doi-asserted-by":"crossref","first-page":"672319","DOI":"10.3389\/fendo.2021.672319","article-title":"Adrenocortical carcinoma steroid profiles: in silico pan-cancer analysis of TCGA data uncovers immunotherapy targets for potential improved outcomes","volume":"12","author":"Muzzi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025040317214943200_bib59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/clinem\/dgz014","article-title":"Development of an adrenocortical cancer humanized mouse model to characterize anti-PD1 effects on tumor microenvironment","volume":"105","author":"Lang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2025040317214943200_bib60","doi-asserted-by":"crossref","first-page":"11101","DOI":"10.3390\/ijms222011101","article-title":"Pan-cancer analysis of clinical relevance via telomere maintenance mechanism","volume":"22","author":"Sung","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025040317214943200_bib61","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/genes14040790","article-title":"ATRX\/DAXX: guarding the genome against the hazards of ALT","volume":"14","author":"Clatterbuck Soper","year":"2023","journal-title":"Genes (Basel)"},{"key":"2025040317214943200_bib62","doi-asserted-by":"crossref","first-page":"e96659","DOI":"10.15252\/embj.201796659","article-title":"ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization","volume":"38","author":"Li","year":"2019","journal-title":"EMBO J"},{"key":"2025040317214943200_bib63","doi-asserted-by":"crossref","first-page":"e1002772","DOI":"10.1371\/journal.pgen.1002772","article-title":"Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway","volume":"8","author":"Lovejoy","year":"2012","journal-title":"PLoS Genet"},{"key":"2025040317214943200_bib64","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/0008-5472.CAN-16-2983","article-title":"Temozolomide in the era of precision medicine","volume":"77","author":"Thomas","year":"2017","journal-title":"Cancer Res"},{"key":"2025040317214943200_bib65","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1073\/pnas.1205943109","article-title":"Putative DNA\/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents","volume":"109","author":"Zoppoli","year":"2012","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0100\/3485860\/crc-24-0100.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/9\/2384\/3513306\/crc-24-0100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/9\/2384\/3513306\/crc-24-0100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:43:14Z","timestamp":1743727394000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/9\/2384\/748398\/A-Database-Tool-Integrating-Genomic-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0100","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.27336341","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336353","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336359","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336329","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336335","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727374","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336347","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985498.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727371","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985504","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985513.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985510","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985510.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336332","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985507","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336350","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336338","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985501.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336344","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727365","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336356","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27336368","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985507.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985504.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28727362","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985498","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985513","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26985501","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7443225.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7443225","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}